This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Zacks.com featured highlights include: Catalyst Biosciences, UFP Industries, VeriSign, InMode and Castle Biosciences
by Zacks Equity Research
Zacks.com featured highlights include: Catalyst Biosciences, UFP Industries, VeriSign, InMode and Castle Biosciences
5 Stocks Set to Pop on New Analyst Coverage
by Shrabana Mukherjee
Increased analyst coverage over the last few weeks might lead to solid price appreciation for stocks like Catalyst Biosciences (CBIO), UFP Industries (UFPI), VeriSign (VRSN), InMode (INMD) and Castle Biosciences (CSTL).
Stock Investors: What's the Next Hot Industry?
by Tracey Ryniec
Technology won't always be on top. There's a bunch of budding industries that could prove to be winners over the next 5 years.
Find Strong Stocks with this New Analyst Coverage Screener
by Benjamin Rains
We screened for strong stocks that recently received new analyst coverage, as we enter the heart of Q3 earnings season...
Zacks.com featured highlights include: Perion Network, Live Oak Bancshares, LexinFintech and InMode
by Zacks Equity Research
Zacks.com featured highlights include: Perion Network, Live Oak Bancshares, LexinFintech and InMode
4 Stocks in Focus on New Analyst Coverage
by Shrabana Mukherjee
Increased analyst coverage over the last few weeks might lead to solid price appreciation for stocks like Perion (PERI), Live Oak (LOB), LexinFintech (LX) and InMode (INMD).
Moving Average Crossover Alert: InMode
by Zacks Equity Research
InMode is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
Surging Earnings Estimates Signal Upside for InMode (INMD) Stock
by Zacks Equity Research
InMode (INMD) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
InMode (INMD) Surges: Stock Moves 10.6% Higher
by Zacks Equity Research
InMode (INMD) saw a big move last session, as its shares jumped more than 10% on the day, amid huge volumes.
InMode (INMD) Gains But Lags Market: What You Should Know
by Zacks Equity Research
InMode (INMD) closed the most recent trading day at $28.07, moving +0.36% from the previous trading session.
InMode (INMD) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
InMode (INMD) closed at $31.15 in the latest trading session, marking a +1.1% move from the prior day.
InMode (INMD) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, InMode (INMD) closed at $31.15, marking a -1.61% move from the previous day.
InMode (INMD) to Post Q1 Earnings: What's in the Offing?
by Zacks Equity Research
InMode's (INMD) Q1 performance is likely to have been driven by developments in business segments amid coronavirus-led supply disruptions.
InMode (INMD) Gains But Lags Market: What You Should Know
by Zacks Equity Research
InMode (INMD) closed at $24.94 in the latest trading session, marking a +1.96% move from the prior day.
Zacks.com featured highlights include: DHT, Blucora, InMode and Enphase Energy
by Zacks Equity Research
Zacks.com featured highlights include: DHT, Blucora, InMode and Enphase Energy
4 Stocks With High Net Income Ratio to Scoop Up
by Nitish Marwah
Profitability analysis is one of the best ways to evaluate the prospects of a company.
InMode (INMD) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, InMode (INMD) closed at $21.98, marking a -0.86% move from the previous day.
The Zacks Analyst Blog Highlights: InMode, Integer, Cardinal Health, DaVita and The Ensign Group
by Zacks Equity Research
The Zacks Analyst Blog Highlights: InMode, Integer, Cardinal Health, DaVita and The Ensign Group
5 Stocks to Buy for 5 Good Reasons
by Sejuti Banerjea
Here are 5 ways to make the most of a difficult market.
6 Defensive Stocks Worth Buying as Coronavirus Cases Rise
by Zacks Equity Research
The current economic slowdown led by rise in coronavirus cases calls for investing in defensive stocks.
Vapotherm (VAPO) in Focus: Stock Moves 6.2% Higher
by Zacks Equity Research
Vapotherm (VAPO) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.
Medtronic (MDT) in Focus: Stock Moves 8% Higher
by Zacks Equity Research
Medtronic (MDT) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.
Zacks Value Trader Highlights: Applied Materials, Garmin, InMode, Microsoft and Synaptics
by Zacks Equity Research
Zacks Value Trader Highlights: Applied Materials, Garmin, InMode, Microsoft and Synaptics
Coronavirus Worries? Screen for Stocks with Management Excellence
by Tracey Ryniec
With the coronavirus sell-off increasing worries about debt, here are 5 companies with low debt to equity ratios.
InMode, Kraft Heinz, Heico, Leidos and L3Harris Technologies highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
InMode, Kraft Heinz, Heico, Leidos and L3Harris Technologies highlighted as Zacks Bull and Bear of the Day